Heart Failure

Featured Article

The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview

The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview

To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.

Latest Features

The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview

The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview

To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.

Managing Heart Failure: Improving Quality of Life and Preventing Excerbations

Managing Heart Failure: Improving Quality of Life and Preventing Excerbations

Heart failure is the number 1 reason for patient re-admittance to acute-care facilities according to the American Heart Association.

Preventing Heart Failure One Risk Factor at a Time

Preventing Heart Failure One Risk Factor at a Time

Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.

Hope for Heart Failure in Thyroid Hormone Therapy

Hope for Heart Failure in Thyroid Hormone Therapy

Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.

Premature Ventricle Contractions in Heart Failure: A Closer Examination

Premature Ventricle Contractions in Heart Failure: A Closer Examination

A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.

Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"

Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"

Drs Tauras and Patel from Montefiore Medical Center in the Bronx, New York weigh in on what the new heart failure therapeutic guidelines mean for practicing clinicians.

Managing Cardiovascular Complications of Oncology Treatment

Managing Cardiovascular Complications of Oncology Treatment

Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.

Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure

Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure

Ixmyelocel-T therapy reduced clinical cardiac events and improved patient outcomes.

Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD

Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD

Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.

Latest News

LV Strain, Hypertrophy Predict Heart Failure in Asymptomatic T2D

LV Strain, Hypertrophy Predict Heart Failure in Asymptomatic T2D

Impaired global longitudinal strain and left ventricular hypertrophy may be predictive of incident heart failure in patients with asymptomatic type 2 diabetes.

Acute Myocarditis Complicated by LVSD Has Different Presentation, Outcomes

Acute Myocarditis Complicated by LVSD Has Different Presentation, Outcomes

Acute myocarditis complicated by left ventricular systolic dysfunction confers a higher risk for cardiac death and heart transplant compared with uncomplicated acute myocarditis.

Neprilysin Inhibition May Reduce Renal Function Deterioration in Comorbid T2D and Chronic Heart Failure

Neprilysin Inhibition May Reduce Renal Function Deterioration in Comorbid T2D and Chronic Heart Failure

This study aimed to examine the efficacy of neprilysin inhibition in treating renal disease in individuals with T2D.

FDA Recall: HeartMate 3™ Outflow Graft Assembly Malfunction

FDA Recall: HeartMate 3 Outflow Graft Assembly Malfunction

The HeartMate 3™ Left Ventricular Assist System has been recalled because of a potential malfunction in the outflow graft assembly that may cause it to twist and close up over time.

Single-Beat Approach Estimates Preload Recruitable Stroke Work Relationship in PAH

Single-Beat Approach Estimates Preload Recruitable Stroke Work Relationship in PAH

A single-beat estimation of preload recruitable stroke work and its coupling with pulmonary arterial load in pulmonary arterial hypertension provided high accuracy for evaluating right ventricular contractility.

AHA: Right-Sided Heart Failure Evaluation, Management Guidelines

AHA: Right-Sided Heart Failure Evaluation, Management Guidelines

The American Heart Association scientific statement offers recommendations on right-sided heart failure regarding physical examination, serum markers, and imaging.

Sleep Apnea Diagnosis in Heart Failure Using Portable Monitor

Sleep Apnea Diagnosis in Heart Failure Using Portable Monitor

Portable sleep monitoring may accurately diagnose sleep apnea in patients who are hospitalized with heart failure.

Sacubitril/Valsartan vs Enalapril for Physical Activity Improvement in HFrEF

Sacubitril/Valsartan vs Enalapril for Physical Activity Improvement in HFrEF

Sacubitril/valsartan was associated with greater improvements in physical and social activities in patients with heart failure with reduced ejection fraction than enalapril.

Sacubitril/Valsartan May Help Preserve Kidney Function in Patients With HFrEF

Sacubitril/Valsartan May Help Preserve Kidney Function in Patients With HFrEF

Compared with the enalapril-treated group, those treated with sacubitril/valsartan were found to have significantly slower kidney decline (-1.3 vs -1.8mL/min/1.73m2 per year; P<0.0001).

ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation

ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation

New Class 1 recommendations involve the referral of inpatients and outpatients to cardiac rehabilitation programs that include exercise training.

Sign Up for Free e-Newsletters